Funder: Novo Nordisk Foundation
Due Dates: October 7, 2026 (Stage 1: Expression of Interest) | February 10, 2027 (Stage 2: Full Proposal)
Funding Amounts: DKK 30–75 million (approx. EUR 4–10 million) per grant for up to 6 years; total budget DKK 150 million (EUR 20 million).
Summary: Supports interdisciplinary research consortia to develop rapid, minimally invasive, and globally deployable diagnostics for antimicrobial-resistant lower respiratory tract infections.
Key Information: Main applicant must be based at a European institution; at least one partner must be at a Danish institution.